| Product Code: ETC7744365 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Japan's oral antiviral import market saw a diverse range of countries contributing to its supply, with Germany, Switzerland, USA, Italy, and Metropolitan France leading the pack. Despite the low concentration indicated by the Herfindahl-Hirschman Index (HHI), the market experienced a decline in compound annual growth rate (CAGR) from 2020 to 2024 at -5.32%. The growth rate for 2023-24 was also negative at -3.46%, reflecting a challenging period for this sector. Overall, the import dynamics suggest a competitive landscape with fluctuating trends in the Japanese oral antiviral market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Oral Antiviral Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Oral Antiviral Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Oral Antiviral Market - Industry Life Cycle |
3.4 Japan Oral Antiviral Market - Porter's Five Forces |
3.5 Japan Oral Antiviral Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Japan Oral Antiviral Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.7 Japan Oral Antiviral Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
4 Japan Oral Antiviral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of viral infections in Japan |
4.2.2 Rising awareness about the importance of early treatment with oral antivirals |
4.2.3 Advances in technology leading to the development of more effective oral antiviral medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of oral antiviral drugs |
4.3.2 High competition among existing oral antiviral drug manufacturers |
4.3.3 Limited reimbursement policies for oral antiviral medications in Japan |
5 Japan Oral Antiviral Market Trends |
6 Japan Oral Antiviral Market, By Types |
6.1 Japan Oral Antiviral Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Japan Oral Antiviral Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Japan Oral Antiviral Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.1.4 Japan Oral Antiviral Market Revenues & Volume, By Human Immunodeficiency Virus (HIV), 2021- 2031F |
6.1.5 Japan Oral Antiviral Market Revenues & Volume, By Influenza, 2021- 2031F |
6.1.6 Japan Oral Antiviral Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Oral Antiviral Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Japan Oral Antiviral Market Revenues & Volume, By Protease inhibitors, 2021- 2031F |
6.2.3 Japan Oral Antiviral Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F |
6.2.4 Japan Oral Antiviral Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Oral Antiviral Market, By Distribution channel |
6.3.1 Overview and Analysis |
6.3.2 Japan Oral Antiviral Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.3.3 Japan Oral Antiviral Market Revenues & Volume, By Drug store and retail pharmacies, 2021- 2031F |
6.3.4 Japan Oral Antiviral Market Revenues & Volume, By Online providers, 2021- 2031F |
7 Japan Oral Antiviral Market Import-Export Trade Statistics |
7.1 Japan Oral Antiviral Market Export to Major Countries |
7.2 Japan Oral Antiviral Market Imports from Major Countries |
8 Japan Oral Antiviral Market Key Performance Indicators |
8.1 Number of prescriptions for oral antiviral drugs |
8.2 Patient adherence rate to oral antiviral treatment |
8.3 Rate of new oral antiviral drug approvals |
9 Japan Oral Antiviral Market - Opportunity Assessment |
9.1 Japan Oral Antiviral Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Japan Oral Antiviral Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.3 Japan Oral Antiviral Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
10 Japan Oral Antiviral Market - Competitive Landscape |
10.1 Japan Oral Antiviral Market Revenue Share, By Companies, 2024 |
10.2 Japan Oral Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here